330 related articles for article (PubMed ID: 25158944)
1. Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy.
Lavinsky D; Palanker D
Retina; 2015 Feb; 35(2):213-22. PubMed ID: 25158944
[TBL] [Abstract][Full Text] [Related]
2. Selective Retina Therapy in Acute and Chronic-Recurrent Central Serous Chorioretinopathy.
Framme C; Walter A; Berger L; Prahs P; Alt C; Theisen-Kunde D; Kowal J; Brinkmann R
Ophthalmologica; 2015; 234(4):177-88. PubMed ID: 26368551
[TBL] [Abstract][Full Text] [Related]
3. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
4. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
Yadav NK; Jayadev C; Mohan A; Vijayan P; Battu R; Dabir S; Shetty B; Shetty R;
Eye (Lond); 2015 Feb; 29(2):258-64; quiz 265. PubMed ID: 25613846
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
Silva RM; Ruiz-Moreno JM; Gomez-Ulla F; Montero JA; Gregório T; Cachulo ML; Pires IA; Cunha-Vaz JG; Murta JN
Retina; 2013 Feb; 33(2):309-15. PubMed ID: 23095766
[TBL] [Abstract][Full Text] [Related]
6. Central serous chorioretinopathy treated with navigated retinal laser photocoagulation: visual acuity and retinal sensitivity.
Mastropasqua L; Di Antonio L; Toto L; Mastropasqua A; Di Iorio A; Carpineto P
Ophthalmic Surg Lasers Imaging Retina; 2015 Mar; 46(3):349-54. PubMed ID: 25856822
[TBL] [Abstract][Full Text] [Related]
7. COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Cheng CK; Chang CK; Peng CH
Retina; 2017 Feb; 37(2):325-333. PubMed ID: 27429374
[TBL] [Abstract][Full Text] [Related]
8. Low-intensity/high-density subthreshold microPulse diode laser for chronic central serous chorioretinopathy.
Malik KJ; Sampat KM; Mansouri A; Steiner JN; Glaser BM
Retina; 2015 Mar; 35(3):532-6. PubMed ID: 25127050
[TBL] [Abstract][Full Text] [Related]
9. The effect of nondamaging subthreshold laser therapy in patients with chronic central serous chorioretinopathy.
Lee SH; Lee J; Kim M; Roh YJ
Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1433-1442. PubMed ID: 38010518
[TBL] [Abstract][Full Text] [Related]
10. Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients.
Park YG; Kang S; Kim M; Yoo N; Roh YJ
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1375-1383. PubMed ID: 28421342
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment.
Ueda T; Gomi F; Suzuki M; Sakaguchi H; Sawa M; Kamei M; Nishida K
Retina; 2012 Feb; 32(2):308-13. PubMed ID: 21869614
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Lim SJ; Roh MI; Kwon OW
Retina; 2010 Jan; 30(1):100-6. PubMed ID: 20010322
[TBL] [Abstract][Full Text] [Related]
13. Half-fluence photodynamic therapy in acute central serous chorioretinopathy.
Smretschnig E; Ansari-Shahrezaei S; Moussa S; Glittenberg C; Krebs I; Binder S
Retina; 2012; 32(10):2014-9. PubMed ID: 22466482
[TBL] [Abstract][Full Text] [Related]
14. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Grzybowski A
Graefes Arch Clin Exp Ophthalmol; 2017 Dec; 255(12):2299-2306. PubMed ID: 28831603
[TBL] [Abstract][Full Text] [Related]
15. Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy.
Yasui A; Yamamoto M; Hirayama K; Shiraki K; Theisen-Kunde D; Brinkmann R; Miura Y; Kohno T
Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):243-254. PubMed ID: 27497611
[TBL] [Abstract][Full Text] [Related]
16. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
17. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Manabe S; Shiragami C; Hirooka K; Izumibata S; Tsujikawa A; Shiraga F
Am J Ophthalmol; 2015 Apr; 159(4):644-51. PubMed ID: 25595669
[TBL] [Abstract][Full Text] [Related]
18. Focal laser ablation of retinal angiomatous proliferation.
Johnson TM; Glaser BM
Retina; 2006 Sep; 26(7):765-72. PubMed ID: 16963849
[TBL] [Abstract][Full Text] [Related]
19. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.
Kim JY; Park HS; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2129-35. PubMed ID: 25717024
[TBL] [Abstract][Full Text] [Related]
20. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
